@article{3c33c87b3c1d4ab29f0a54809153f128,
title = "How to administrate erythropoietin, intravenous or subcutaneous?",
abstract = "To determine whether adding recombinant erythropoietin to the intravenous (IV) solution and administering it as a 24-h continuous infusion would result in an erythropoietic effect not inferior to that seen with subcutaneous (SC) administration.",
keywords = "Anemia, Blood Transfusion, Erythropoietin, Female, Humans, Hypodermoclysis, Infant, Newborn, Infant, Premature, Infusions, Intravenous, Male, Recombinant Proteins, Reticulocyte Count, Transferrin, Anemia, Blood Transfusion, Erythropoietin, Female, Humans, Hypodermoclysis, Infant, Newborn, Infant, Premature, Infusions, Intravenous, Male, Recombinant Proteins, Reticulocyte Count, Transferrin",
author = "Francesca Gallini and Luca Maggio and Simonetta Costa and Costantino Romagnoli and Zuppa, {Antonio Alberto} and Francesco Cota",
year = "2013",
doi = "10.1111/apa.12193",
language = "English",
volume = "102",
pages = "579--583",
journal = "ACTA PAEDIATRICA",
issn = "0803-5253",
publisher = "Taylor & Francis Limited:Rankine Road, Basingstoke RG24 8PR United Kingdom:011 44 1256 813035, EMAIL: madeline.sims@tandf.co.uk, info@tandf.co.uk, INTERNET: http://www.tandf.co.uk, Fax: 011 44 1256 330245 Editore precedente: Universitetsforlaget, Oslo",
}